“Fiscal 2019 was a transformative year for Medmen, with over two million completed retail transactions to date and revenues increasing 227% year-over-year,” said Adam Bierman, Medmen co-founder and chief executive officer in a news release that should see the company gutted on the markets Tuesday.
When a gentleman or mademoiselle makes a decision to honour the dark arts of predatory investing, occasions such as these times, when the black clouds of doom envelope the otherwise pleasant meadow that is the public markets, require one to seek out not the healthiest of companies, for they have already ascended to the heavens. Rather, one should seek out the decrepit, the beaten, and the damned, for they can be turned inexpensively and profited from completely.
I had an idea a few weeks ago, one that I hadn’t bothered with sooner because, truth be told, I’m not a weed guy. I like the investment opportunity, and I’ve lately taken to the wonderful effects of CBD, but I’m not much of a straight up weed dog.
Chemesis International (CSI.C) closed its all-shares deal to acquire controlling interest in Puerto Rico based GSRX Industries today.
Andy DeFrancesco is the devil. Just ask anyone. The worst guy in the weed business, the archangel of bad asset deals, the shell master of Florida. He’s got investigative journalists who write about nothing other than him, he’s got shareholders at various companies that have bought things from him screaming at him for taking their treasure, he’s got trolls all day long and seems almost to revel in the abuse.
Lifestyle Delivery Systems (LDS.C) and TransCanna Holdings (TCAN.C) want to forget about their merger attempt
Lifestyle Delivery Systems (LDS.C) wants so badly for you to forget all about its failed merger with TransCanna Holdings (TCAN.C) that it’s willing to remind you that it’s now selling CannaStrips in 10 dispensaries.